November 7, 2011
ViiV Establishes HIV Drug Manufacturing Partnership in Russia
ViiV Healthcare, an HIV company formed by Pfizer and GlaxoSmithKline, has established a pharmaceutical manufacturing partnership with Russian drugmaker Binnopharm, Reuters reports. This follows a pledge by a dozen international pharmaceutical companies to invest more than $1 billion in Russia as the country tries to reduce its dependence on drug imports. Industry research group Pharmexpert says that the Russian market for HIV drugs topped $500 million in 2010, with more than half of those sales coming from two manufacturers—GlaxoSmithKline and Abbott Laboratories.
To read the Reuters article, click here.
Search: HIV, Russia, GlaxoSmithKline, Pfizer, ViiV, Binnopharm, Abbott Laboratories, Pharmexpert, drug companies
Scroll down to comment on this story.
Show comments (0 total)
[Go to top]